Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Top Publications
Paavonen, J, Naud, P, Salmerón, J, Wheeler, C, Chow, S-N, Apter, D, Kitchener, H, Castellsague, X, Teixeira, J, Skinner, et al.
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
The Lancet
374(9686)
:
301 -314
2009
view publication
Joura, EA, Garland, SM.
Cervical Cancers After Human Papillomavirus Vaccination.
Obstetrics and Gynecology
114(1)
:
174 -175
2009
view publication
Garland, SM, Insinga, RP, Sings, HL, Haupt, RM, Joura, EA.
Human Papillomavirus Infections and Vulvar Disease Development.
Cancer Epidemiology Biomarkers & Prevention
18(6)
:
1777 -1784
2009
view publication
Pirotta, MV, Stein, AN, Fairley, CK, Morrow, A, Conway, EL, Chuah, J, McCloskey, J, McNulty, A, Waddell, R, Carter, R, et al.
Patterns of Treatment of External Genital Warts in Australian Sexual Health Clinics.
Sexually Transmitted Diseases
36(6)
:
375 -379
2009
view publication
Pitts, M, Smith, A, Croy, S, Lyons, A, Ryall, R, Garland, S, Wong, ML, Hseon, TE.
Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Vaccine
27(22)
:
2989 -2993
2009
view publication